BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Theravance, Inc. (THRX) CEO: The Elan Corporation PLC (ELN) Vote Doesn't Mean Much


6/21/2013 7:53:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Over the past few weeks, Theravance has made headlines several times. First, the drugmaker decided to split into two companies – one that will manage respiratory drugs that comprise a partnership with GlaxoSmithKline and another that will focus on drug discovery. Then, the FDA approved its Breo inhaled treatment for chronic obstructive pulmonary disorder. Finally, Elan agreed to pay $1 billion in exchange for royalties that Theravance receives from its Glaxo deal. But then Elan shareholders voted against the move amid an unsolicited takeover bid by Royalty Pharma. Just the same, Theravance ceo Rick Winningham, not surprisingly, appeared sanguine during recent conversations about his plans.

Help employers find you! Check out all the jobs and post your resume.


Read at Pharmalot

Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES